Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RIGL Rigel Pharmaceuticals

交易中 11-22 10:12:37 EST

25.62

+0.58

+2.32%

最高25.85	最低25.34	成交量1.09万
今开25.34	昨收25.04	日振幅2.02%
总市值4.51亿	流通市值3.83亿	总股本1,762万
成交额27.73万	换手率0.07%	流通股本1,494万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RIGL","market":"US","secType":"STK","nameCN":"Rigel Pharmaceuticals","latestPrice":25.62,"timestamp":1732288354186,"preClose":25.04,"halted":0,"volume":10858,"delay":0,"floatShares":14942447,"shares":17615040,"eps":0.22143,"marketStatus":"交易中","marketStatusCode":2,"change":0.58,"latestTime":"11-22 10:12:37 EST","open":25.34,"high":25.8451,"low":25.34,"amount":277347.479268,"amplitude":0.020172,"askPrice":25.7,"askSize":600,"bidPrice":25.53,"bidSize":20,"shortable":3,"etf":0,"ttmEps":0.22143,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":975474000000,"adjPreClose":25.04,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":25.4,"preClose":25.04,"latestTime":"08:12 EST","volume":12,"amount":304.05999599999996,"timestamp":1732281143291},"postHourTrading":{"tag":"盘后","latestPrice":25.438,"preClose":25.04,"latestTime":"19:59 EST","volume":654,"amount":16471.781,"timestamp":1732237188540},"volumeRatio":0.424973,"impliedVol":0.5518,"impliedVolPercentile":0.2629},"requestUrl":"/m/hq/s/RIGL","defaultTab":"news","newsList":[{"id":"2484773903","title":"Rigel Pharmaceuticals, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484773903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484773903?lang=zh_cn&edition=full","pubTime":"2024-11-20 05:00","pubTimestamp":1732050019,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日05时00分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.10%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.64%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Abpro Holdings Inc C/Wts 12/11/2029 、Exicure, Inc.涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1354.05%、860.66%、168.31%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、78.21%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120050020971a7844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120050020971a7844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2484130609","title":"Rigel Pharmaceuticals, Inc.盘中异动 大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484130609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484130609?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:44","pubTimestamp":1731951867,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时44分，Rigel Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.19%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Hcw Biologics Inc.、冠科美博、Tharimmune, Inc.较为活跃，换手率分别为1106.86%、719.02%、565.87%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博，振幅分别为563.48%、129.51%、95.10%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901442898e4351b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111901442898e4351b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2484287510","title":"Rigel Pharmaceuticals, Inc.2024财年第三财季实现净利润12.42百万美元，同比增加318.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484287510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484287510?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:04","pubTimestamp":1731773040,"startTime":"0","endTime":"0","summary":"11月17日，Rigel Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为12.42百万美元，同比增加318.28%；其中营业收入为55.31百万美元，同比增加96.62%，每股基本收益为0.71美元。从资产负债表来看，Rigel Pharmaceuticals, Inc.总负债1.54亿美元，其中短期债务466000.00美元，资产负债比为0.91，流动比率为0.02。机构评级：截至2024年11月17日，当前有6家机构对Rigel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为29.17美元，其中最低目标价为14.00美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000518abc79185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000518abc79185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL"],"gpt_icon":0},{"id":"2483940800","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.35%报28.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483940800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483940800?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:24","pubTimestamp":1731597887,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时24分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.35%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药涨幅较大，Elevai Labs, Inc.、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为2591.88%、58.72%、36.59%，振幅较大的相关个股有Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.，振幅分别为83.43%、75.00%、73.28%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232447abc177eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232447abc177eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2483882016","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.25%报25.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882016?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:04","pubTimestamp":1731510285,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时04分，Rigel Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.25%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为364.42%、218.46%、92.80%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.，振幅分别为44.21%、36.31%、28.72%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230446971a64f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230446971a64f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2482086563","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.41%报26.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482086563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482086563?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:46","pubTimestamp":1731422796,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时46分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.41%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Geovax Labs, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为137.87%、132.14%、59.98%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Heron Therapeutics, Inc.，振幅分别为49.39%、34.55%、26.63%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222463698e4216e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222463698e4216e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2482382097","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.44%报23.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482382097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482382097?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335494,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.44%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为406.28%、124.81%、60.99%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Oragenics Inc.、Aptevo Therapeutics Inc.，振幅分别为22.57%、9.87%、7.01%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223135abb66126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223135abb66126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2481310100","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨18.20%报18.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481310100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481310100?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076345,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Rigel Pharmaceuticals, Inc.股票出现异动，股价快速拉升18.20%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Fortrea Holdings Inc.、Tenaya Therapeutics, Inc.、Rigel Pharmaceuticals, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为381.59%、16.43%、13.96%，振幅较大的相关个股有Anebulo Pharmaceuticals, Inc.、Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.，振幅分别为14.96%、14.91%、14.90%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822322595bdef16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822322595bdef16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2481808041","title":"Rigel Pharmaceuticals, Inc.盘中异动 快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481808041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481808041?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:44","pubTimestamp":1730994257,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时44分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.24%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Ensysce Biosciences, Inc.、Celularity Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为726.64%、154.95%、94.22%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234417a221127c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107234417a221127c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2481931209","title":"Rigel Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.17%报15.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481931209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481931209?lang=zh_cn&edition=full","pubTime":"2024-11-07 02:09","pubTimestamp":1730916598,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日02时09分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.17%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107020958971a4d9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107020958971a4d9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2474058412","title":"Rigel Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.29%报14.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474058412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474058412?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:13","pubTimestamp":1728501223,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时13分，Rigel Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.29%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为726.88%、573.81%、250.17%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100313439719f50e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100313439719f50e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2473877964","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报15.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473877964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473877964?lang=zh_cn&edition=full","pubTime":"2024-10-08 03:03","pubTimestamp":1728327795,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日03时03分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.11%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1663.11%、92.77%、60.66%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lakeshore Biopharma Co., Ltd，振幅分别为107.82%、39.46%、38.72%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080303159719eb69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080303159719eb69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2472356084","title":"Rigel Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.05%报15.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472356084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472356084?lang=zh_cn&edition=full","pubTime":"2024-10-01 03:48","pubTimestamp":1727725727,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日03时48分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报15.59美元/股，成交量23.7144万股，换手率1.35%，振幅7.49%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001034847a1ddbefe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001034847a1ddbefe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2470080802","title":"Rigel Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.13%报16.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470080802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470080802?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:48","pubTimestamp":1727448516,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时48分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.13%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3732.35%、191.01%、116.40%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为152.50%、60.69%、51.69%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722483798e396e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722483798e396e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2469758491","title":"Rigel Pharmaceuticals, Inc.盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469758491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469758491?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:34","pubTimestamp":1727184884,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时34分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.23%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Seelos Therapeutics, Inc.、Capricor Therapeutics, Inc.、Wave Life Sciences Ltd.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Capricor Therapeutics, Inc.较为活跃，换手率分别为957.30%、149.24%、13.55%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Onconetix, Inc.、Capricor Therapeutics, Inc.，振幅分别为41.53%、20.11%、19.51%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213444ab65a55d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213444ab65a55d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2459211401","title":"Rigel Pharmaceuticals, Inc.盘中异动 快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459211401","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459211401?lang=zh_cn&edition=full","pubTime":"2024-08-16 02:56","pubTimestamp":1723748218,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日02时56分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.30%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Portage Biotech Inc.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为10874.33%、2344.99%、655.55%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc.、Nutriband Inc C/Wts ，振幅分别为163.33%、162.60%、115.79%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816025658ab5dde37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816025658ab5dde37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL","BK4139"],"gpt_icon":0},{"id":"2459988907","title":"Rigel Pharmaceuticals, Inc.盘中异动 快速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459988907","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459988907?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:32","pubTimestamp":1723559578,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时32分，Rigel Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.07%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813223258aefea018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813223258aefea018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2458899149","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458899149","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458899149?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:01","pubTimestamp":1723471273,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时01分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.85%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Oragenics Inc.、Revance Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为57.01%、33.23%、12.25%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc.，振幅分别为40.71%、26.33%、23.72%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081222011398e34d93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081222011398e34d93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0},{"id":"2458927826","title":"Rigel Pharmaceuticals, Inc.2024财年第二财季实现净利润-1.03百万美元，同比增加84.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458927826","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458927826?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:16","pubTimestamp":1723392991,"startTime":"0","endTime":"0","summary":"8月12日，Rigel Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.03百万美元，同比增加84.39%；其中营业收入为36.84百万美元，同比增加37.00%，每股基本收益为-0.06美元。从资产负债表来看，Rigel Pharmaceuticals, Inc.总负债1.58亿美元，其中短期债务639000.00美元，资产负债比为0.82，流动比率为1.62。机构评级：截至2024年8月12日，当前有6家机构对Rigel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为25.92美元，其中最低目标价为11.50美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120016359f222a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120016359f222a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RIGL"],"gpt_icon":0},{"id":"2457593314","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457593314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457593314?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:52","pubTimestamp":1723125125,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时52分，Rigel Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.88%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.10%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Oragenics Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为245.83%、235.86%、123.25%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Entero Therapeutics Inc.，振幅分别为57.58%、40.44%、35.28%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808215206968252e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808215206968252e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RIGL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rigel.com","stockEarnings":[{"period":"1week","weight":-0.0881},{"period":"1month","weight":0.6851},{"period":"3month","weight":1.0064},{"period":"6month","weight":1.7592},{"period":"1year","weight":1.6355},{"period":"ytd","weight":0.7269}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rigel Pharmaceuticals, Inc.于1996年6月14日成立于特拉华州。该公司是一家生物技术公司，致力于发现、开发和提供新疗法，显著改善血液系统疾病和癌症患者的生活。公司首个获FDA批准的产品是TAVALISSE（六水二钠福司他马替尼）片，这是唯一获批的口服脾脏酪氨酸激酶（SYK）抑制剂，用于治疗对先前治疗反应不足的慢性免疫性血小板减少症（ITP）成人患者。该公司第二个获得FDA批准的产品是REZLIDHIA（olutasidenib）胶囊，用于治疗经FDA批准的试验检测出具有易感异柠檬酸脱氢酶-1（IDH1）突变的复发或难治性（R/R）急性髓系白血病（AML）成人患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.027089},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.035362},{"month":3,"riseRate":0.541667,"avgChangeRate":0.022379},{"month":4,"riseRate":0.5,"avgChangeRate":0.025522},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.001104},{"month":6,"riseRate":0.416667,"avgChangeRate":0.009248},{"month":7,"riseRate":0.5,"avgChangeRate":-0.004213},{"month":8,"riseRate":0.416667,"avgChangeRate":0.003459},{"month":9,"riseRate":0.5,"avgChangeRate":0.031455},{"month":10,"riseRate":0.375,"avgChangeRate":-0.064595},{"month":11,"riseRate":0.416667,"avgChangeRate":0.052059},{"month":12,"riseRate":0.5,"avgChangeRate":0.1521}],"exchange":"NASDAQ","name":"Rigel Pharmaceuticals","nameEN":"Rigel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rigel Pharmaceuticals(RIGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rigel Pharmaceuticals,RIGL,Rigel Pharmaceuticals股票,Rigel Pharmaceuticals股票老虎,Rigel Pharmaceuticals股票老虎国际,Rigel Pharmaceuticals行情,Rigel Pharmaceuticals股票行情,Rigel Pharmaceuticals股价,Rigel Pharmaceuticals股市,Rigel Pharmaceuticals股票价格,Rigel Pharmaceuticals股票交易,Rigel Pharmaceuticals股票购买,Rigel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rigel Pharmaceuticals(RIGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况